Esmael, Abdulatip .
HRN: 24-37-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
CO-AMOXICLAV 625MG (TAB)
01/06/2024
01/13/2024
PO
625mg
Q8hrs
Punctured Chest
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes